Schedule 13G ownership disclosure

CRESCENT BIOPHARMA INC.

Ordinary Shares, $0.001 par value per share · CUSIP: G2545C104

Event date: 2025-10-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 700,000.00 · Class: 5.04%

  • KEVIN TANG

    Shares: 700,000.00 · Class: 5.04%

  • TANG CAPITAL PARTNERS, LP

    Shares: 393,681.00 · Class: 2.84%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 306,319.00 · Class: 2.20%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0.0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-014813
Form type
SCHEDULE 13G
Filer
CRESCENT BIOPHARMA, INC.
CIK
CIK 1253689
Filed
Oct 09, 2025
Reporting period
Oct 02, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub